TP53 and malignant colon neoplasm: In colon-cancer cells with DNA damage triggered by chemotherapy drugs, p53-R175H, p53-R248W, and p53-R273H upregulate ephrin-B2 coding gene EFNB2 by binding to its promoter companies by NF-Y and p300.